zum Inhalt

MD MPH FACP Klaus LINDPAINTNER Vizepräsident Forschung & Entwicklung und Chief Scientific Officer, SDIX - Strategic Diagnostics Inc., Newark


 Klaus Lindpaintner is Vice President of Research and Development and Chief Scientific Officer at SDIX, a specialty immunosolutions provider active in biomarker science and biotherapeutics. Previously, he held senior management positions at F Hoffman-La Roche, most recently as Director of the Roche Molecular Medicine Laboratories in Basel, coordinating the company s efforts and activities in implementing biomarker research based on genetics, genomics, proteomics and associated disciplines across the value chain from early discovery to late-stage clinicaltrials. He has co-authored more than 250 scientific papers, and currently holds honorary and adjunct professorships at several academic institutions. He has served on numerous working groups and advisory panels for trade organizations, regulatory authorities and nongovernmental organizations on issues related to the ethical and societal impact of novel technologies in biomedicine. He graduated from Innsbruck University Medical School with a degree in medicine and from Harvard University with a degree in public health. He pursued post-graduate training and specialization in internal medicine, cardiology, and genetics in the US and Germany and holds board certification in these specialties. He pursued clinical practice in these areas and academic research in molecular genetics and genetic epidemiology while an Associate Professor of Medicine at Harvard Medical School. He is married to Lyn, an internist-geriatrician, and has two daughters who are pursuing undergraduate and graduate training. In his leisure time he likes to pursue high-altitude mountaineering, photography, and travel.